From Mechanism to Market

For 20 years Rosa has delivered insights to our clients that would be impossible to obtain in any other way.

PhysioPD Research

PhysioPD® Research is a proprietary approach that translates the physiology, disease pathophysiology, and drug pharmacology of interest into a customized and interactive mathematical Research Platform. PhysioPD delivers credible insights that would be impossible to obtain in any other way. It is used by scientists and clinicians to clarify the connection between disease mechanisms, therapeutic interventions, and clinical outcomes. The result is that decision-makers have a dramatic increase in confidence to develop successful clinical trials and product submissions.

Learn more about PhysioPD Research
PhysioPD Research

ForecastMD Platform

Rosa's ForecastMD™ Platform credibly identifies what product attributes drive physician uptake. Rosa's proprietary methods and technology can explore a breadth of product profiles and competitive scenarios that would be impossible to explore in any other way. The client receives a durable asset that can be used to fine-tune product features and demonstrate the potential commercial demand in a variety of current and future competitive scenarios over multiple years.

Learn more about ForecastMD

Explore our Worldwide Webinar Series

Rosa’s "Impact" webinar series is renowned for its informative discussions on the use of computer modeling and simulation within the global research and development community. Register for an upcoming webinar or download a webinar from the archives.

Explore Webinars

Recent Highlights

Rosa & Co. announces the publication of an article on modeling in cancer immunotherapy

Rosa & Co. announced today the publication of an article titled, “From Cold to Hot: Changing Perceptions and Future Opportunities for Quantitative Systems Pharmacology (QSP) Modeling in Cancer Immunotherapy,” which was published online ahead of p... Read More

Rosa & Co. announces the publication of an article on modeling the amyloid pathway in Alzheimer’s Disease

Rosa & Co. announced today the publication of an article titled, “Quantitative Systems Pharmacology Model of the Amyloid Pathway in Alzheimer’s Disease: Insights into the Therapeutic Mechanisms of Clinical Candidates,” which was published online ... Read More

Rosa & Co presents at ACoP13

Rosa & Co. is pleased to announce the presentation of two posters at the 2022 ACoP13 meeting. The posters ‘QSP Model of Aß Accumulation Predicts Different Treatment Effects at Different Stages of Alzheimer’s Disease.’ and ‘Higher Fentanyl Exposur... Read More

Rosa will attend the Cell and Gene Therapy Strategy Meeting

Matt Marano, Chief Commercial Officer for Rosa & Co. will be attending the upcoming Cell and Gene Therapy Strategy Meeting: Europe 2022 on Tuesday, October 11, 2022. See the following link for more details. https://proventainternational.com/211-p... Read More

"Rosa is all about doing better science"
—Christina Friedrich, PhD, Chief Engineer, PhysioPD
Learn about PhysioPD Research